Viewing Study NCT02517502


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-21 @ 2:26 PM
Study NCT ID: NCT02517502
Status: COMPLETED
Last Update Posted: 2022-01-24
First Post: 2015-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy
Sponsor: Carol Fabian, MD
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STUDY00002415
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View